BioXcel Therapeutics, Inc. (BTAI) scores 15 out of 100 on boothcheck's 11-model valuation framework. Verdict: Strong Avoid The estimated fair value is $0.03, representing a 98% premium to fair value. Quantitative score: 33/100. Qualitative score: 20/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.